HealthCor Management as of Dec. 31, 2017
Portfolio Holdings for HealthCor Management
HealthCor Management holds 36 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merck & Co (MRK) | 7.1 | $220M | 3.9M | 56.27 | |
| Bioverativ Inc Com equity | 6.6 | $202M | 3.8M | 53.92 | |
| Zimmer Holdings (ZBH) | 6.4 | $196M | 1.6M | 120.67 | |
| Celgene Corporation | 5.9 | $180M | 1.7M | 104.36 | |
| Laboratory Corp. of America Holdings (LH) | 5.7 | $176M | 1.1M | 159.51 | |
| Medtronic (MDT) | 5.1 | $158M | 2.0M | 80.75 | |
| Allergan | 4.4 | $135M | 825k | 163.58 | |
| Incyte Corporation (INCY) | 4.2 | $128M | 1.4M | 94.71 | |
| Pacira Pharmaceuticals (PCRX) | 4.2 | $128M | 2.8M | 45.65 | |
| Regeneron Pharmaceuticals (REGN) | 4.0 | $122M | 325k | 375.96 | |
| Neurocrine Biosciences (NBIX) | 3.9 | $118M | 1.5M | 77.59 | |
| Baxter International (BAX) | 3.6 | $112M | 1.7M | 64.64 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.5 | $109M | 725k | 149.86 | |
| Haemonetics Corporation (HAE) | 2.7 | $84M | 1.5M | 58.08 | |
| CVS Caremark Corporation (CVS) | 2.6 | $82M | 1.1M | 72.50 | |
| Intuitive Surgical (ISRG) | 2.6 | $81M | 222k | 364.94 | |
| Iqvia Holdings (IQV) | 2.5 | $77M | 783k | 97.90 | |
| Sarepta Therapeutics (SRPT) | 2.4 | $73M | 1.3M | 55.64 | |
| Abbvie (ABBV) | 2.4 | $73M | 749k | 96.71 | |
| Anthem (ELV) | 2.3 | $71M | 316k | 225.01 | |
| UnitedHealth (UNH) | 2.3 | $69M | 315k | 220.46 | |
| Mednax (MD) | 2.2 | $67M | 1.3M | 53.44 | |
| Clovis Oncology | 2.2 | $66M | 974k | 68.00 | |
| Humana (HUM) | 2.1 | $65M | 263k | 248.07 | |
| Livanova Plc Ord (LIVN) | 1.6 | $50M | 623k | 79.92 | |
| Zoetis Inc Cl A (ZTS) | 1.5 | $47M | 645k | 72.04 | |
| Tenet Healthcare Corporation (THC) | 1.5 | $45M | 3.0M | 15.16 | |
| Johnson & Johnson (JNJ) | 0.9 | $27M | 195k | 139.72 | |
| Stryker Corporation (SYK) | 0.8 | $26M | 166k | 154.84 | |
| Bristol Myers Squibb (BMY) | 0.8 | $25M | 405k | 61.28 | |
| Corindus Vascular Robotics I | 0.7 | $20M | 20M | 1.01 | |
| Abbott Laboratories (ABT) | 0.5 | $14M | 245k | 57.07 | |
| Danaher Corporation (DHR) | 0.4 | $12M | 125k | 92.82 | |
| Boston Scientific Corporation (BSX) | 0.3 | $9.1M | 368k | 24.79 | |
| Mallinckrodt Pub | 0.2 | $6.4M | 284k | 22.56 | |
| Five Prime Therapeutics | 0.1 | $2.2M | 101k | 21.92 |
